USFDA APPLICATION NUMBER - 203341 / DOSAGE - TABLET;ORAL - EQ 400MG BASE
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
BOSUTINIB MONOHYDRATE(UNII: 844ZJE6I55) (BOSUTINIB - UNII:5018V4AEZ0) | BOSUTINIB | 100mg | 50mg | 400mg | 500mg | 100mg |
Inactive Ingredients
Ingredient Name | Pfizer Laboratories Div Pfizer Inc |
---|---|
AMMONIA(5138Q19F1X) | |
CROSCARMELLOSE SODIUM(M28OL1HH48) | |
FERRIC OXIDE RED(1K09F3G675) | |
FERRIC OXIDE YELLOW(EX438O2MRT) | |
FERROSOFERRIC OXIDE(XM0M87F357) | |
GELATIN, UNSPECIFIED(2G86QN327L) | |
MAGNESIUM STEARATE(70097M6I30) | |
MANNITOL(3OWL53L36A) | |
MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |
POLOXAMER 188(LQA7B6G8JG) | |
POLYETHYLENE GLYCOL 3350(G2M7P15E5P) | |
POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990) | |
POTASSIUM HYDROXIDE(WZH3C48M4T) | |
POVIDONE K25(K0KQV10C35) | |
PROPYLENE GLYCOL(6DC9Q167V3) | |
SHELLAC(46N107B71O) | |
TALC(7SEV7J4R1U) | |
TITANIUM DIOXIDE(15FIX9V2JP) |
LOOKING FOR A SUPPLIER?